[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CY2021004I1 - Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης - Google Patents

Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης

Info

Publication number
CY2021004I1
CY2021004I1 CY2021004C CY2021004C CY2021004I1 CY 2021004 I1 CY2021004 I1 CY 2021004I1 CY 2021004 C CY2021004 C CY 2021004C CY 2021004 C CY2021004 C CY 2021004C CY 2021004 I1 CY2021004 I1 CY 2021004I1
Authority
CY
Cyprus
Prior art keywords
quinolone compounds
making
making quinolone
compounds
quinolone
Prior art date
Application number
CY2021004C
Other languages
English (en)
Other versions
CY2021004I2 (el
Original Assignee
Melinta Subsidiary Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melinta Subsidiary Corp. filed Critical Melinta Subsidiary Corp.
Publication of CY2021004I1 publication Critical patent/CY2021004I1/el
Publication of CY2021004I2 publication Critical patent/CY2021004I2/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16HGEARING
    • F16H57/00General details of gearing
    • F16H57/02Gearboxes; Mounting gearing therein
    • F16H57/027Gearboxes; Mounting gearing therein characterised by means for venting gearboxes, e.g. air breathers
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16HGEARING
    • F16H57/00General details of gearing
    • F16H57/02Gearboxes; Mounting gearing therein
    • F16H57/037Gearboxes for accommodating differential gearings
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16HGEARING
    • F16H48/00Differential gearings
    • F16H48/06Differential gearings with gears having orbital motion
    • F16H48/08Differential gearings with gears having orbital motion comprising bevel gears
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16HGEARING
    • F16H57/00General details of gearing
    • F16H57/04Features relating to lubrication or cooling or heating
    • F16H57/0457Splash lubrication
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16HGEARING
    • F16H57/00General details of gearing
    • F16H57/04Features relating to lubrication or cooling or heating
    • F16H57/048Type of gearings to be lubricated, cooled or heated
    • F16H57/0482Gearings with gears having orbital motion
    • F16H57/0483Axle or inter-axle differentials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T74/00Machine element or mechanism
    • Y10T74/19Gearing
    • Y10T74/19642Directly cooperating gears
    • Y10T74/19688Bevel
    • Y10T74/19693Motor vehicle drive
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T74/00Machine element or mechanism
    • Y10T74/21Elements
    • Y10T74/2186Gear casings
    • Y10T74/2188Axle and torque tubes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
CY2021004C 2008-09-24 2021-02-10 Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης CY2021004I2 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19408308P 2008-09-24 2008-09-24
PCT/US2009/005276 WO2010036329A2 (en) 2008-09-24 2009-09-23 Process for making quinolone compounds
EP17163383.7A EP3214083B1 (en) 2008-09-24 2009-09-23 Process for making quinolone compounds
EP09816565.7A EP2346855B1 (en) 2008-09-24 2009-09-23 Process for making quinolone compounds

Publications (2)

Publication Number Publication Date
CY2021004I1 true CY2021004I1 (el) 2021-05-05
CY2021004I2 CY2021004I2 (el) 2021-05-05

Family

ID=42060333

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20201101168T CY1123658T1 (el) 2008-09-24 2020-12-09 Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης
CY2021004C CY2021004I2 (el) 2008-09-24 2021-02-10 Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20201101168T CY1123658T1 (el) 2008-09-24 2020-12-09 Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης

Country Status (27)

Country Link
US (3) US8497378B2 (el)
EP (3) EP3214083B1 (el)
JP (2) JP6013734B2 (el)
KR (3) KR20170039758A (el)
CN (2) CN105001207A (el)
AU (1) AU2009297085B2 (el)
BR (1) BRPI0919241B8 (el)
CA (1) CA2738236C (el)
CY (2) CY1123658T1 (el)
DK (2) DK2346855T3 (el)
ES (3) ES2966093T3 (el)
FI (1) FI3766876T3 (el)
HK (2) HK1214243A1 (el)
HR (1) HRP20201879T1 (el)
HU (2) HUE052219T2 (el)
IL (1) IL211845A (el)
LT (3) LT3214083T (el)
MX (2) MX2011003122A (el)
NL (1) NL301091I2 (el)
NO (1) NO2021006I1 (el)
PL (2) PL3214083T3 (el)
PT (1) PT3214083T (el)
RS (1) RS61194B1 (el)
RU (1) RU2546667C2 (el)
SG (1) SG10201605492YA (el)
SI (1) SI3214083T1 (el)
WO (1) WO2010036329A2 (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576216B2 (en) * 2004-07-30 2009-08-18 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
ES2966093T3 (es) * 2008-09-24 2024-04-18 Melinta Subsidiary Corp Formulación farmacéutica que contiene un derivado de quinolona
TW201444558A (zh) * 2013-03-15 2014-12-01 Melinta Therapeutics Inc 使用喹諾酮類抗生素治療淋病感染的方法
CN104098548B (zh) * 2013-04-11 2017-07-18 上海医药工业研究院 一种Delafloxacin的精制方法
CN103709100A (zh) * 2013-12-31 2014-04-09 南京工业大学 一种8-氯代喹诺酮衍生物的制备方法
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
CN106256824B (zh) * 2015-06-18 2020-10-27 重庆医药工业研究院有限责任公司 一种高纯度德拉沙星葡甲胺盐的制备方法
CN105017224A (zh) * 2015-07-10 2015-11-04 扬子江药业集团有限公司 一种德拉沙星葡甲胺晶型的制备方法
CN107778293B (zh) * 2016-08-29 2023-06-16 鲁南制药集团股份有限公司 一种改进的德拉沙星的制备方法
AU2018246563B2 (en) 2017-03-31 2020-07-30 Fujifilm Corporation 4-Pyridone compound or salt thereof, and pharmaceutical composition and formulation including same
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
CN113527262B (zh) * 2021-06-22 2022-07-15 安徽普利药业有限公司 一种德拉沙星及其葡甲胺盐的精制方法
CN114031607B (zh) * 2021-11-16 2023-01-10 海南普利制药股份有限公司 一种德拉沙星及其中间体的精制方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
PT952151E (pt) 1995-09-22 2003-10-31 Wakunaga Pharma Co Ltd Intermediarios para utilizacao na preparacao de novos derivados de acido piridonacarboxilico ou seus sais
JP3477465B2 (ja) * 1999-07-01 2003-12-10 湧永製薬株式会社 キノリンカルボン酸誘導体又はその塩
JP2005097116A (ja) 1999-11-11 2005-04-14 Wakunaga Pharmaceut Co Ltd キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法
ES2506143T3 (es) * 2004-07-30 2014-10-13 Abbvie Inc. Preparación de sustancias antibacterianas de ácido piridonacarboxílico
PT3056492T (pt) 2004-10-08 2021-12-27 Abbvie Inc Sal de meglumina e formas cristalinas do mesmo de um fármaco (delafloxacina)
EP1868581B1 (en) 2005-04-11 2012-03-14 Abbott Laboratories Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
ES2966093T3 (es) 2008-09-24 2024-04-18 Melinta Subsidiary Corp Formulación farmacéutica que contiene un derivado de quinolona

Also Published As

Publication number Publication date
EP2346855B1 (en) 2017-04-05
EP3214083B1 (en) 2020-09-16
BRPI0919241B1 (pt) 2020-05-12
LTPA2021002I1 (lt) 2021-03-10
ES2629466T3 (es) 2017-08-09
WO2010036329A3 (en) 2010-07-01
NL301091I1 (nl) 2021-02-10
RS61194B1 (sr) 2021-01-29
KR20160116020A (ko) 2016-10-06
BRPI0919241A8 (pt) 2017-10-17
US8497378B2 (en) 2013-07-30
PL3214083T3 (pl) 2021-04-06
FI3766876T3 (fi) 2023-12-05
MX2011003122A (es) 2011-07-20
PL3766876T3 (pl) 2024-04-02
ES2826273T3 (es) 2021-05-17
LT3214083T (lt) 2021-01-25
EP3766876A1 (en) 2021-01-20
AU2009297085B2 (en) 2015-07-09
NL301091I2 (nl) 2021-08-03
USRE46617E1 (en) 2017-11-28
RU2011116052A (ru) 2012-10-27
NO2021006I1 (no) 2021-02-15
SG10201605492YA (en) 2016-09-29
LTC3214083I2 (lt) 2022-06-27
MX2020009790A (es) 2020-10-12
BRPI0919241B8 (pt) 2021-05-25
US8871938B2 (en) 2014-10-28
HK1214243A1 (zh) 2016-07-22
EP2346855A2 (en) 2011-07-27
CA2738236A1 (en) 2010-04-01
JP2015178515A (ja) 2015-10-08
JP6013734B2 (ja) 2016-10-25
HUS2100004I1 (hu) 2021-03-01
CN102164912A (zh) 2011-08-24
ES2966093T3 (es) 2024-04-18
DK2346855T3 (en) 2017-07-24
US20120041208A1 (en) 2012-02-16
IL211845A0 (en) 2011-06-30
KR101775304B1 (ko) 2017-09-05
HUE052219T2 (hu) 2021-04-28
LT3766876T (lt) 2023-12-11
EP2346855A4 (en) 2012-07-04
SI3214083T1 (sl) 2021-02-26
AU2009297085A1 (en) 2010-04-01
IL211845A (en) 2017-03-30
JP2012508161A (ja) 2012-04-05
EP3766876B8 (en) 2023-10-18
CY2021004I2 (el) 2021-05-05
PT3214083T (pt) 2020-12-04
BRPI0919241A2 (pt) 2016-06-21
CY1123658T1 (el) 2021-05-05
CA2738236C (en) 2016-11-15
KR20110091504A (ko) 2011-08-11
RU2546667C2 (ru) 2015-04-10
CN102164912B (zh) 2015-08-19
KR20170039758A (ko) 2017-04-11
US20140171648A1 (en) 2014-06-19
HK1244481A1 (zh) 2018-08-10
WO2010036329A2 (en) 2010-04-01
DK3214083T3 (da) 2020-12-07
EP3214083A1 (en) 2017-09-06
EP3766876B1 (en) 2023-09-13
CN105001207A (zh) 2015-10-28
HRP20201879T1 (hr) 2021-01-22

Similar Documents

Publication Publication Date Title
CY2021004I1 (el) Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης
BRPI0919116A2 (pt) método
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BR112012004707A2 (pt) método
BR112012000624A2 (pt) método
BRPI0817726A2 (pt) Método
DK2313489T3 (da) Fremstillingsmetode
FI20090389A0 (fi) Menetelmä
BRPI0920707A2 (pt) compostos
DK2242759T3 (da) Forbindelser
BRPI0920540A2 (pt) método de produção de álcool
BRPI1012526A2 (pt) método
BRPI0906705A2 (pt) Composto heterocíclicos
DK2323972T3 (da) C7-fluor-substituerede tetracylinforbindelser
DK2358661T3 (da) Fremgangsmåde til fremstilling af trans-4-amino-cyclohexyl-eddikesyreethylester-hcl
BRPI0922490A2 (pt) Método para produção de beta-santaleno
DK2297162T3 (da) Forbindelser
BRPI0911625A2 (pt) Métodos
JP2008297558A5 (ja) 重合方法
BRPI0807973A2 (pt) Método de enrolamento de propriedades uniformes
BRPI0916432A2 (pt) compostos
DK2346661T3 (da) Dannelsesfremgangsmåder
BRPI0916597A2 (pt) Método
BRPI1009350A2 (pt) método